{
    "nct_id": "NCT06234605",
    "official_title": "A Phase 1b, Open-Label, Safety, Tolerability, and Efficacy Study of HC- 7366 in Combination With Belzutifan (WELIREGâ„¢) in Patients With Locally Advanced or Metastatic Renal Cell Carcinoma",
    "inclusion_criteria": "* Has diagnosis of locally advanced (inoperable) or metastatic RCC with a predominant clear cell component\n* Be age 18 years or older (male or female) at the time of consent\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "",
    "miscellaneous_criteria": ""
}